医学
血压
导管
期限(时间)
荟萃分析
去神经支配
内科学
心脏病学
重症监护医学
外科
量子力学
物理
作者
Gianni Sesa-Ashton,Janis M. Nolde,Ida Muente,Revathy Carnagarin,Vaughan G. Macefield,Tye Dawood,Élisabeth Lambert,Gavin Lambert,Antony Walton,Murray Esler,Markus P. Schlaich
出处
期刊:Hypertension
[Ovid Technologies (Wolters Kluwer)]
日期:2024-06-01
卷期号:81 (6)
被引量:2
标识
DOI:10.1161/hypertensionaha.123.22314
摘要
Renal denervation is a recognized adjunct therapy for hypertension with clinically significant blood pressure (BP)-lowering effects. Long-term follow-up data are critical to ascertain durability of the effect and safety. Aside from the 36-month follow-up data available from randomized control trials, recent cohort analyses extended follow-up out to 10 years. We sought to analyze study-level data and quantify the ambulatory BP reduction of renal denervation across contemporary randomized sham-controlled trials and available long-term follow-up data up to 10 years from observational studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI